This webinar equips you with the latest updates and insights on conducting due diligence for life sciences acquisitions in the context of the ever-evolving legal, regulatory and compliance landscape of 2023.
The content of this program does not meet requirements for continuing legal education (CLE) accreditation. You will not receive CLE credit for participating.